biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > This thread as become my new site for entertainment

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Mar 17, 2022 5:54pm

60 Views

Post# 34523452

RE:RE:RE:RE:RE:This thread as become my new site for entertainment

About RVX, it's hard to believe you're still yapping about that thing. You, darnit, went for years with no posting. You haven't the courage to post unless you're sure there some other trolls to back you up.

The days of ignoring trolls are over. Go ahead. I'v e been at it for years and the other crazies somehow think your posts today are going to drive me away.

Bioasis is worth supporting, not shorting. What a stupid comment that was. You don't even know that xB3 IS NOT A DRUG.

jd

<< Previous

Bullboard Posts

Next >>

Rich TV Live’s Stocks to Watch this week (Nov. 15, 2024)